BioPharm International, October 2006

Columns and Departments

Streettalk:Why Poker Players Make Great Investors

By Brian O'Connell

Fear leads to bad decisions on a Wall Street trading floor, or at a high-stakes Vegas poker table.

Outsourcing: Procurement Pros Shrink Supplier Base

By Jim Miller

A major shift is occurring in the way the biopharmaceutical industry sources goods and services. Price pressures at the retail end of the value chain and a difficult fundraising environment are forcing biopharmaceutical companies to take greater control of their costs. Purchased goods and services, including contract research and manufacturing services as well as raw materials and laboratory supplies, are a major expense in most companies, so control of those purchasing decisions is coming in for special scrutiny.

Article

Virus Removal by Filtration: Points to Consider

By Gerd Kern , Mani Krishnan

It is important to ensure that flow decay during processing is comparable to that observed during retention studies.

Featured Article

Enhanced Packaging and Reformulations Give New Life to Biologics

By Tom Polen

Formulations for pulmonary inhalation comprise spherical, porous particles that are 1–3 microns in diameter.

Articles

Successful Technology Transfer Requires More Than Technical Know-How

By Jeff R. Dudley

We often assume we know what success looks like for our partner, but we never ask them, or take the time to write it down.

A Guide for Testing Biopharmaceuticals Part 2: Acceptance criteria and analytical method maintenance

By Stephan Krause, PhD

The first part of this article, published in the September 2006 issue, discussed general strategies for validation extensions to other test method components, laboratories and even different test methods.1This second part provides practical tips on how to maintain test method suitability long after the formal completion of analytical method validation (AMV) studies.